Literature DB >> 7878477

Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.

B Klein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7878477

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  12 in total

1.  Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells.

Authors:  Teru Hideshima; Laurence Catley; Hiroshi Yasui; Kenji Ishitsuka; Noopur Raje; Constantine Mitsiades; Klaus Podar; Nikhil C Munshi; Dharminder Chauhan; Paul G Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

Review 2.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

3.  Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.

Authors:  M Mittelman; D Neumann; A Peled; P Kanter; N Haran-Ghera
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

4.  Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.

Authors:  G Lattanzio; C Libert; M Aquilina; M Cappelletti; G Ciliberto; P Musiani; V Poli
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

Review 5.  Therapy strategies for multiple myeloma: current status.

Authors:  Heinz Gisslinger; Mathias Kees
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

6.  Serum transforming growth factor-beta 1 is related to the degree of immunoparesis in patients with multiple myeloma.

Authors:  M C Kyrtsonis; C Repa; G V Dedoussis; A Mouzaki; A Simeonidis; M Stamatelou; A Maniatis
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

Review 7.  Bone marrow microenvironment and the identification of new targets for myeloma therapy.

Authors:  K Podar; D Chauhan; K C Anderson
Journal:  Leukemia       Date:  2008-10-09       Impact factor: 11.528

8.  Multiple myeloma: VI International Workshop, June 14-18, 1997, Boston, Massachusetts, USA.

Authors:  S Bergenbrant
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

Review 9.  Homing behaviour of the malignant cell clone in multiple myeloma.

Authors:  I Van Riet; K Vanderkerken; C de Greef; B Van Camp
Journal:  Med Oncol       Date:  1998-09       Impact factor: 3.064

10.  Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma.

Authors:  Oksana Zavidij; Nicholas J Haradhvala; Tarek H Mouhieddine; Romanos Sklavenitis-Pistofidis; Songjie Cai; Mairead Reidy; Mahshid Rahmat; Abdallah Flaifel; Benjamin Ferland; Nang K Su; Michael P Agius; Jihye Park; Salomon Manier; Mark Bustoros; Daisy Huynh; Marzia Capelletti; Brianna Berrios; Chia-Jen Liu; Meng Xiao He; Esteban Braggio; Rafael Fonseca; Yosef E Maruvka; Jennifer L Guerriero; Melissa Goldman; Eliezer M Van Allen; Steven A McCarroll; Jamil Azzi; Gad Getz; Irene M Ghobrial
Journal:  Nat Cancer       Date:  2020-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.